MX2025001366A - Capsulas de gel blando de disolucion rapida - Google Patents

Capsulas de gel blando de disolucion rapida

Info

Publication number
MX2025001366A
MX2025001366A MX2025001366A MX2025001366A MX2025001366A MX 2025001366 A MX2025001366 A MX 2025001366A MX 2025001366 A MX2025001366 A MX 2025001366A MX 2025001366 A MX2025001366 A MX 2025001366A MX 2025001366 A MX2025001366 A MX 2025001366A
Authority
MX
Mexico
Prior art keywords
fast dissolving
softgel capsules
softgel
film
capsules
Prior art date
Application number
MX2025001366A
Other languages
English (en)
Spanish (es)
Inventor
Soo Ah Jin
Qi Fang
Karunakar Sukuru
Aris Gennadios
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of MX2025001366A publication Critical patent/MX2025001366A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2025001366A 2022-08-12 2025-01-31 Capsulas de gel blando de disolucion rapida MX2025001366A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263397554P 2022-08-12 2022-08-12
PCT/US2023/030042 WO2024035911A1 (en) 2022-08-12 2023-08-11 Fast dissolving softgel capsules

Publications (1)

Publication Number Publication Date
MX2025001366A true MX2025001366A (es) 2025-03-07

Family

ID=89852410

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025001366A MX2025001366A (es) 2022-08-12 2025-01-31 Capsulas de gel blando de disolucion rapida

Country Status (13)

Country Link
US (1) US20250057774A1 (enExample)
EP (1) EP4568657A1 (enExample)
JP (1) JP2025527331A (enExample)
KR (1) KR20250047815A (enExample)
CN (1) CN119907662A (enExample)
AR (1) AR130185A1 (enExample)
AU (1) AU2023321676A1 (enExample)
CA (1) CA3263875A1 (enExample)
CO (1) CO2025002953A2 (enExample)
MX (1) MX2025001366A (enExample)
TW (1) TW202408464A (enExample)
UY (1) UY40394A (enExample)
WO (1) WO2024035911A1 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60238269D1 (de) * 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
KR101288079B1 (ko) * 2010-08-04 2013-07-22 알.피.쉐러 테크놀러지즈 엘엘씨 연질캡슐용 막 형성 조성물
PT2689774T (pt) * 2011-03-21 2019-04-05 Broda Tech Co Ltd Composições de hidrogel termo-reversíveis reversivamente
EP2968081A4 (en) * 2013-03-15 2016-08-10 Banner Life Sciences Llc MOLLE ENTERIC CAPSULES NOT CONTAINING GELATIN
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN114667084B (zh) * 2019-10-09 2024-11-15 R.P.谢勒技术有限公司 非动物性软凝胶胶囊制剂、其制备方法及使用方法
CN113332257B (zh) * 2021-06-28 2023-05-05 仙乐健康科技股份有限公司 软胶囊囊壳和软胶囊
KR20240037990A (ko) * 2021-07-06 2024-03-22 알.피.쉐러 테크놀러지즈 엘엘씨 소프트겔 캡슐

Also Published As

Publication number Publication date
AR130185A1 (es) 2024-11-13
EP4568657A1 (en) 2025-06-18
CO2025002953A2 (es) 2025-03-27
CN119907662A (zh) 2025-04-29
US20250057774A1 (en) 2025-02-20
AU2023321676A1 (en) 2025-03-20
JP2025527331A (ja) 2025-08-20
WO2024035911A9 (en) 2024-12-26
UY40394A (es) 2024-02-15
KR20250047815A (ko) 2025-04-04
WO2024035911A1 (en) 2024-02-15
TW202408464A (zh) 2024-03-01
CA3263875A1 (en) 2024-02-15

Similar Documents

Publication Publication Date Title
CN100358509C (zh) 采用hpmc胶囊进行肠和结肠传递
ES2582942T3 (es) Composiciones farmacéuticas de liberación controlada que comprenden un éster de ácido fumárico
CN102824333B (zh) 一种口腔速溶膜剂及其制备方法
MX2008015360A (es) Formulaciones farmaceuticas de fenilefrina y composiciones para su absorcion en el colon.
PL207776B1 (pl) Kompozycja farmaceutyczna o zmodyfikowanym uwalnianiu
JP2021524477A (ja) 自己調節性の浸透性胃保持性薬物送達システム
CA3103477A1 (en) Formulations of 5-hydroxy tryptophan (5-htp) for better bioavailability for various indications
CN109985016B (zh) 一种非布司他的控释组合物及其制备方法
MX2022003883A (es) Formulaciones en capsulas de gel blando de origen no animal, metodos de preparacion y metodos de uso de las mismas.
MX2025001366A (es) Capsulas de gel blando de disolucion rapida
CN103550191A (zh) 一种布洛芬及其盐无痛微针透皮贴剂及其制备方法
Bajpai et al. Design and in vitro evaluation of compression-coated pulsatile release tablets of losartan potassium
WO2005063219A2 (en) Ibuprofen-containing soft gelatin capsules
CN112451531B (zh) 一种阿司匹林和利伐沙班复方制剂及其制备方法
CA2449520A1 (en) Swallow tablet comprising paracetamol
CN104546807A (zh) 奥氮平口腔速溶膜剂
CN1642537A (zh) 用于硬壳胶囊的布洛芬溶液
CN105663096A (zh) 一种沃诺拉赞口腔速溶膜剂及其制备方法
EP3866758A1 (en) Softgels with solid or gel-like polymeric fill matrix
CA2965256A1 (en) Novel pharmaceutical formulation
CN104721166A (zh) 一种丁基苯酞液体硬胶囊制剂及其制备方法
TW200800155A (en) Gastric retentive gabapentin dosage forms and methods for using same
EP4090313A1 (en) Sustained release compositions comprising liothyronine
US20160000734A1 (en) Method and compositions of civamide to treat disease of the intestines
Gao et al. Design and development of supersaturatable self-emulsifying drug delivery systems for enhancing the gastrointestinal absorption of poorly soluble drugs